For this purpose, the human cancer cell lines Ramos and PC-3 were chosen, considering that CD98hc was described as a promising tumor marker for lymphoma 26 as well as other hematological cancers 15 and is known to be overexpressed in metastatic prostate cancer 25, 76. This evidence concerns the gene SLC3A2 and hematopoietic and lymphoid cell neoplasm.